Inhibition of xanthine oxidase can alter HF progression in dilated cardiomyopathy

Source :: Science Letter. November 8, 2005, 670
Publication Year :: 2005
Abstract: Chronic xanthine oxidase inhibition prevents myofibrillar protein oxidation and preserves cardiac function in a transgenic mouse model of cardiomyopathy. Scientists in the United States report, "Heart failure is a clinical [...]

Subjects :: Johns Hopkins University -- Reports
Heart diseases -- Reports
Cardiomyopathy, Dilated -- Reports
Molybdenum compounds -- Reports
Drugs -- Reports
Oxidases -- Reports
Cardiomyopathy -- Reports
Purines -- Reports
Health
Science and technology
Reports

Tools